KJHP
MDNA

K.J. Harrison & Partners’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

K.J. Harrison & Partners’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,000
Closed -$17K – 390
2021
Q4 		$17K Hold
10,000
– – ﹤0.01% 345
2021
Q3 		$27K Buy
+10,000
New +$24.8K ﹤0.01% 333

Other funds holding MDNA

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
MCWS
McKinley Carter Wealth Services Wheeling, West Virginia $1.94B AUM 20.7% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

K.J. Harrison & Partners's MDNA Position: Q1 2022 in Review

K.J. Harrison & Partners sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q1 2022, closing a stake of 10,000 shares — an estimated $17K sold.

K.J. Harrison & Partners first reported a position in MDNA in Q3 2021 and held it in 2 quarters. The position peaked at $27K in Q3 2021. 20 funds tracked by Wall St. Rank hold MDNA as of Q1 2022.

  • K.J. Harrison & Partners reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q1 2022 after selling out during the quarter.
  • K.J. Harrison & Partners sold 10,000 Medicenna Therapeutics Corp. Common Shares shares in Q1 2022, an estimated $17K.
  • K.J. Harrison & Partners first reported a position in Medicenna Therapeutics Corp. Common Shares in Q3 2021 and held it in 2 quarters.
  • K.J. Harrison & Partners's Medicenna Therapeutics Corp. Common Shares position peaked at $27K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q1 2022.

Based on K.J. Harrison & Partners's 13F filing for Q1 2022, filed 21 Apr 2022.